All articles by Eoin Ryan
Eoin Ryan
Patching the problem of EU drug shortages
According to committee members, there is a risk that US drug shortages could worsen under the Inflation Reduction Act (IRA) price controls for prescription medicines.
EC’s proposed pharma reforms spark industry discontent
This blog explores the key areas of concern for pharmaceutical companies and some of the potential implications of these reforms.
Inflationary storm clouds will continue to buffet global pharma industry in 2023
The pharma industry may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US.
New dawn for the EU’s joint procurement crisis response
The upcoming changes to the EU’s joint procurement rules will apply in instances of ‘serious cross-border threats to health’.
How horizon scanning can help predict the future for EU’s Alzheimer’s disease market
Aduhelm’s US launch has prompted a new look into what is in store for the Alzheimer’s disease market over the coming years.
